Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 25 2024
0mins
Source: Newsfilter
Company Name Change: Acasti Pharma Inc. will change its name to Grace Therapeutics, Inc. and begin trading on Nasdaq under the symbol "GRCE" starting October 28, 2024, reconnecting with its roots in scientific innovation related to its drug GTx-104 for aneurysmal subarachnoid hemorrhage.
Upcoming Event: Grace Therapeutics will host a Virtual Key Opinion Leader event on November 20, 2024, to discuss GTx-104, which is currently in clinical development and aims to address significant unmet medical needs in patients suffering from aSAH.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
